Injectable Bioactive Giomer Composite vs Hall Technique for Proximal Cavities in Primary Molars
Summary
A randomized clinical trial has been registered on ClinicalTrials.gov (NCT07552129) comparing the survival rate and clinical performance of injectable bioactive giomer composite restorations versus the Hall Technique for managing proximal carious lesions (ICDAS 3-4) in primary molars of children aged 3-8 years over a 12-month follow-up period. The study lists dental caries as the condition and giomer and Hall technique as the interventions under study. This registry entry documents the trial protocol and recruitment parameters for interested clinical investigators and institutional review boards.
“This randomized clinical trial compares the survival rate and clinical performance of injectable bioactive giomer composite restorations versus the Hall Technique for managing proximal carious lesions (ICDAS 3-4) in primary molars of children aged 3-8 years over a 12-month follow-up period.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This ClinicalTrials.gov registry entry documents a newly registered randomized clinical trial comparing two treatments for proximal carious lesions in primary molars. The trial will directly compare injectable bioactive giomer composite restorations to the Hall Technique (a non-restorative stainless steel crown approach) for managing ICDAS 3-4 carious lesions in children aged 3-8 years, with a primary endpoint of survival rate at 12 months.
For dental researchers, pediatric dentists, and institutional review boards, this registration provides protocol parameters useful for identifying potential collaborative sites, assessing evidence gaps in direct head-to-head comparisons of these two treatment philosophies, and monitoring recruitment status. The giomer intervention represents a newer bioactive restorative material class, making this trial potentially informative for evolving standards of care in pediatric dentistry.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Injectable Bioactive Composite vs Hall Technique for Proximal Cavities in Primary Molars
N/A NCT07552129 Kind: NA Apr 27, 2026
Abstract
This randomized clinical trial compares the survival rate and clinical performance of injectable bioactive giomer composite restorations versus the Hall Technique for managing proximal carious lesions (ICDAS 3-4) in primary molars of children aged 3-8 years over a 12-month follow-up period.
Conditions: Dental Caries
Interventions: giomer, hall technique
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.